PT  - JOURNAL ARTICLE
AU  - Muhammad Arif Nadeem Saqib
AU  - Ashar Malik
AU  - Ibrar Rafique
AU  - Faiz Ahmed Raza
AU  - Obaidullah
AU  - Shaimuna Fareeha Sajjad
AU  - Sumera Abid
AU  - Rukhsana Majid
AU  - Tahira Kamal
AU  - Ziauddin Islam
TI  - Economic burden of smoking attributed illnesses in Pakistan
AID  - 10.1101/2020.06.15.20131425
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.15.20131425
4099  - http://medrxiv.org/content/early/2020/06/17/2020.06.15.20131425.short
4100  - http://medrxiv.org/content/early/2020/06/17/2020.06.15.20131425.full
AB  - Background The estimates of economic burden due to smoking attributed illnesses provide an opportunity to assess its overall impact on the economy and generate evidence for public health policy interventions for tobacco control. In this study, we estimated out of pocket expenditures on tobacco attributed illnesses and smoking attributable burden in Pakistan.Methods We used a prevalence-based disease-specific cost approach by including three major tobacco attributed illnesses i.e. lung cancer, chronic obstructive pulmonary disease, and cardiovascular diseases. Our analysis included out of pocket healthcare expenditures including direct and indirect costs which were estimated by interviewing the patients of selected illnesses. The smoking-attributable expenditure was calculated by the WHO tool kit.Results In 2018, the economic burden attributed to smoking related illnesses was Rs 192 billion (USD 1.3 billion). Smoking-attributable expenditure on cardiovascular disease was Rs 123 billion (USD 0.9 billion) which was 69% of the total economic cost of tobacco attributed illnesses in Pakistan. The economic cost in males was nearly three times higher than females.Conclusions Our study showed a significant economic burden due to tobacco attributed illnesses in Pakistan which can be prevented by implementing tobacco control policies effectively.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Pakistan Health Research Council (Grant No./72/2016/MCS)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethical Clearance was obtained from Institutional Bioethics Committee of Pakistan Health Research Council, Islamabad.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe will share all data once the MS is publihsed